Skip to main content

Table 1 Patients’ demographic characteristics

From: Effectiveness of intratracheal salbutamol in addition to surfactant on the clinical course of newborns with respiratory distress syndrome: a clinical trial

Variable Surfactant with N.S. (n = 24) Surfactant with Salb. (n = 24) p
G. age (week) 29.70 ± 2.27 30.04 ± 2.07 0.59
B.B.W (g) 1430.83 ± 393.41 1443 ± 267.22 0.89
Gender
 M. 15(62.5 %) 17(70.8 %) 0.54
 F. 9(37.5 %) 7(29.2 %)
Delivery
 C.S. 18(75 %) 19(79.2 %) 0.73
 Vag. 6(25 %) 5(20.8 %)
Perenatal steroid
 Yes 11(45.8 %) 10(41.7 %) 0.77
 No 13(54.2 %) 14(58.3 %)
Curosurf dosage
 1 20(83.3 %) 18(75 %) 0.47
 2 4(16.7 %) 6(25 %)
  1. N.S normal saline, Salb salbutamol, G gestational, B.B.W birth body weight, M male, F female, C.S cesarean section, Vag vaginal